Total Funding
86
85
Total FundingGrant raised
Growth Score 86 in past quarter
2 pts
Heat Score 85 in past quarter
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
7999
Redefining drug development. Replicating human tissues.
- Christine Whiteside: Sr. Executive, Growth
- William Harley: Sr. Tissue Engineer and Business Development and Preclinical Relations
About the Company
VoxCell empowers scientists and drug developers to study drug behavior with unprecedented physiological relevance.
With vascular complexity at the core of our innovation, VoxCell delivers human-like models that accelerate therapeutic discovery and bridge the gap between preclinical and clinical phases. Committed to innovation and excellence,
VoxCell continues to expand its impact on a global scale.
Women Led